Company Active LTD

Company profile

Atlas Endoscopy Limited

Atlas Endoscopy

Atlas Endoscopy Limited is a UK company with status active founded in 2021 based in Yorkshire and the Humber.

CRN
13408099
Founded
2021
Age
5

Overview

Legal name
ATLAS ENDOSCOPY LIMITED
Region
Yorkshire and the Humber
Registered address
NEXUS
DISCOVERY WAY
LEEDS
ENGLAND
LS2 3AA
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

6 events
01 Jun
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

28 Feb
2027

Accounts due

Accounts Due

Next accounts due date

18 May
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

02 Apr
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzUxNDEyODI0OGFkaXF6a2N4

Published 02 Apr 2026 14:43

31 May
2025

Accounts filed

Accounts

Last accounts made up date

19 May
2021

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2022
Funded years
2022, 2023
Age at first award
1 years

Projects

2023 Collaborative R&D Lead participant

Revolutionising colonoscopy - New Product Introduction of a painless magnetic endoscope

1 May 2023 to 30 Apr 2026

Awarded
£1,745,932
Total cost £2,494,188

Early detection and treatment are crucial to improve patient quality-of-life and survival from colorectal diseases. These include cancer (which accounts for more than 881000 deaths annually worldwide) and inflammatory bowel diseases (which affect millions of individuals and increase risk of colorectal cancer). Standard colonoscopy, performed using a flexi...

2023 Collaborative R&D Lead participant

Introducing a new generation of robotic single-use colonoscopes

1 Jan 2023 to 30 Jun 2024

Awarded
£349,722
Total cost £499,603

Early detection is crucial to improve survival from colorectal diseases, including cancer with over 881000 deaths/year globally) and inflammatory bowel diseases (affecting millions). Colonoscopy, performed using a flexible endoscope, is the best method to identify disease and perform minor surgical interventions. Unfortunately, it comes with notable drawb...

2022 Grant for R&D Lead participant

Development of a colon mapping algorithm for intelligent colonoscopy

1 Nov 2022 to 30 Apr 2023

Awarded
£49,500
Total cost £49,500

Early detection is crucial to improve survival from colorectal diseases, including cancer with over 881000 deaths/year globally. Colonoscopy is the best method to identify disease and perform minor surgical interventions. Unfortunately, it comes with notable drawbacks: patient pain and long training required for operators. Moreover, a significant percenta...

Product types

Collaborative R&D Grant for R&D